Skip to main content
. 2020 Mar 16;12(3):203–212. doi: 10.1093/inthealth/ihaa002

Table 1.

Demographic characteristics of the sample

Characteristics 2012 2014 χ2 p-Value
Sample size, n 4235 3656
Age (years), median (SD) 71.19 (10.06) 72.11 (9.58)
Age group (years), n (%)
 18–39 19 (0.45) 7 (0.19) 72.83 <0.01
 40–49 136 (3.21) 67 (1.83)
 50–59 438 (10.34) 266 (7.28)
 60–69 1236 (29.19) 928 (25.38)
 ≥70 2406 (56.81) 2388 (65.32)
Sex, n (%)
 Male 1702 (40.19) 1446 (39.55) 0.33 0.56
 Female 2533 (59.81) 2210 (60.45)
Community, n (%)
 Urban 1700 (40.14) 1451 (39.69) 0.17 0.68
 Rural 2535 (59.86) 2205 (60.31)
Medicinal treatmenta, n (%)
 Yes 1427 (33.78) 2570 (70.74) 1067.97 <0.01
 No 2798 (66.22) 1063 (29.26)
Comorbid disease, n (%)
 Diabetesb
  Yes 992 (23.42) 867 (23.71) 0.09 0.76
  No 3243 (76.58) 2789 (76.29)
 Stroke, n (%)
  Yes 31 (1.57)
  No 1945 (98.43)
 Cardiovascular disease, n (%)
  Yes 465 (23.56%)
  No 1509 (76.44%)
 Kidney disease, n (%)
  Yes 58 (2.94)
  No 1917 (97.06)
Biomarkers, mean (SD)
 AST:ALT ratio 1.51 (2.78)
 ALT (U/L) 20.13 (13.35)
 AST (U/L) 23.5 (13.77)
 Creatinine (μmol/L) 79.75 (28.98)
 Blood urea nitrogen (mmol/L) 6.58 (6.93)
 Tbil (μmol/L) 13.75 (11.76)

aPrescription medication treatment for hypertension or diabetes.

bHypertension and diabetes present in the same individual.

Source: Authors’ field work from 2009 to 2014.